Crewe Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $175K | Sell |
392
-7
| -2% | -$3.12K | 0.02% | 168 |
|
|
2025
Q1 | $193K | Sell |
399
-1
| -0.3% | -$485 | 0.03% | 138 |
|
|
2024
Q4 | $161K | Sell |
400
-163
| -29% | -$65.6K | 0.02% | 162 |
|
|
2024
Q3 | $262K | Buy |
563
+43
| +8% | +$20K | 0.03% | 125 |
|
|
2024
Q2 | $244K | Buy |
520
+3
| +0.6% | +$1.41K | 0.03% | 158 |
|
|
2024
Q1 | $216K | Buy |
+517
| New | +$216K | 0.03% | 163 |
|
|
2023
Q3 | – | Sell |
-552
| Closed | -$194K | – | 915 |
|
|
2023
Q2 | $194K | Buy |
552
+26
| +5% | +$9.15K | 0.03% | 139 |
|
|
2023
Q1 | $166K | Sell |
526
-80
| -13% | -$25.2K | 0.02% | 175 |
|
|
2022
Q4 | $175K | Sell |
606
-105
| -15% | -$30.3K | 0.03% | 167 |
|
|
2022
Q3 | $206K | Buy |
711
+37
| +5% | +$10.7K | 0.04% | 142 |
|
|
2022
Q2 | $190K | Buy |
674
+209
| +45% | +$58.9K | 0.04% | 138 |
|
|
2022
Q1 | $121K | Buy |
465
+320
| +221% | +$83.3K | 0.02% | 159 |
|
|
2021
Q4 | $32K | Buy |
+145
| New | +$32K | 0.01% | 224 |
|
|
2020
Q4 | – | Sell |
-30
| Closed | -$8K | – | 646 |
|
|
2020
Q3 | $8K | Buy |
+30
| New | +$8K | ﹤0.01% | 285 |
|